Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPURE.L Regulatory News (PURE)

  • There is currently no data for PURE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) (PureCircle Limited)

16 Apr 2020 15:08

RNS Number : 9303J
Ingredion Incorporated
16 April 2020
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Ingredion SRSS Holdings Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

-

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

PureCircle Limited

(d) Is the discloser the offeror or the offeree?

OFFEROR

(e) Date position held:

The latest practicable date prior to the disclosure

9 April 2020

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

-

Nil

-

(2) Cash-settled derivatives:

 

Nil

-

Nil

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

-

Nil

-

 

TOTAL:

Nil

-

Nil

-

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

None

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

9 April 2020

Contact name:

Tiffany Willis

Telephone number:

+1 708 551 2592

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FEEKZGMDFVVGGZM
Date   Source Headline
14th Mar 20117:00 amRNSInterim Results and Investor Conference Call
13th Jan 20117:00 amRNSTrading Statement
15th Dec 201012:00 pmRNSAGM Statement
23rd Nov 20107:00 amRNSAGM Statement
9th Nov 20107:00 amRNSLong term incentive plan: Issue of shares
29th Oct 20107:00 amRNSDirector/PDMR Shareholding
28th Oct 20107:00 amRNSRe Audited accounts
23rd Sep 20108:08 amRNSRe Joint Venture
23rd Sep 20107:43 amRNSRe Joint Venture
22nd Sep 20107:00 amRNSRe Joint Venture
22nd Sep 20107:00 amRNSFull Year Results
31st Aug 20107:00 amRNSNotice of Allowance for patent
3rd Aug 20107:00 amRNSStevia Trust Mark marketing campaign
29th Jul 20107:00 amRNSRe Global Quality Leaf Sourcing Strategy
28th Jul 20107:00 amRNSMajor contract wins
27th Jul 20107:00 amRNSInterim Management Statement
27th Jul 20107:00 amRNSProposed Joint Venture
26th Jul 20107:00 amRNSGlobal Sales and Marketing VP appointed
21st Jul 20107:00 amRNSFDA 'No Objection' ruling on new product
25th Jun 201012:02 pmRNSGlobal Stevia Institute announces key members
26th May 20107:00 amRNSLaunch of Global Stevia Institute
5th May 20107:00 amRNSNew products launching at a greater rate
14th Apr 20106:25 pmRNSEFSA evaluates the safety of steviol glycosides
6th Apr 20107:00 amRNSUpdate on New Product Launches
1st Apr 20109:59 amRNSChange of significant Shareholding
30th Mar 201011:18 amRNSIssue of new shares and exercise of options
22nd Mar 20107:00 amRNSHalf Yearly Report
5th Mar 20107:00 amRNSNotice of Results
4th Mar 20107:00 amRNSProduct Launches
26th Feb 20107:00 amRNSManagement changes
22nd Feb 20107:00 amRNSRe Joint Venture
9th Feb 20109:27 amRNSChange of Significant Shareholding
1st Feb 20107:00 amRNSAppointment of Joint Corporate Broker
29th Jan 20107:00 amRNSProduct Launch
14th Jan 20109:09 amRNSRe Agreement
18th Dec 20097:00 amRNSSignificant shareholding
17th Dec 20097:00 amRNSSignificant Shareholders and Notifiable Interest
8th Dec 20099:11 amRNSissue of shares
24th Nov 200910:17 amRNSResult of AGM
23rd Nov 20097:00 amRNSNotifiable Interests
19th Nov 20097:00 amRNSissue of shares
18th Nov 20097:00 amRNSPlacing
16th Nov 20097:00 amRNSPureCircle collaboration with Nestle Malaysia
13th Nov 20097:00 amRNSPureCircle wins major award
11th Nov 20097:00 amRNSExpansion of supply source
6th Nov 20097:00 amRNSProduct Launch
4th Nov 20097:00 amRNSStevia product launches hit 200
2nd Nov 200911:15 amRNSAnnual Financial Report
30th Oct 20097:00 amRNSNotice of AGM
30th Oct 20097:00 amRNSStatement re Collaboration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.